Epiterna (private company)

See something wrong or missing? Let us know
Offices:Lausanne
Business model:B2B

Epiterna is a Swiss health startup working on a high-throughput drug screening platform used for drug evaluation and effect assessment on healthy lifespan, ultimately leading developing products slowing the ageing process and preventing age-related disease, delaying functional decline, and life extension.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 10.58M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Epiterna

Name Criteria
Spain Ability Pharma
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Beckley Psytech
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 10M+ USD
Norway Curida
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Baseimmune
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Denmark Cytoki Pharma
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 10M+ USD
Italy Harg
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Germany Abalos Therapeutics
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany Emergence Therapeutics
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden Oncorena
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 5M - 10M USD
France SafeHeal
58%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • Total raised in a similar range: 10M+ USD
Top